首页> 外文期刊>Medical dosimetry: official journal of the American Association of Medical Dosimetrists >Dosimetric study and in-vivo dose verification for conformal avoidance treatment of anal adenocarcinoma using helical tomotherapy.
【24h】

Dosimetric study and in-vivo dose verification for conformal avoidance treatment of anal adenocarcinoma using helical tomotherapy.

机译:剂量剂量学研究和体内剂量验证,用于采用螺旋体层摄影术对肛门腺癌进行保形避免治疗。

获取原文
获取原文并翻译 | 示例
       

摘要

This study evaluated the efficacy of using helical tomotherapy for conformal avoidance treatment of anal adenocarcinoma. We retrospectively generated step-and-shoot intensity-modulated radiotherapy (sIMRT) plans and helical tomotherapy plans for two anal cancer patients, one male and one female, who were treated by the sIMRT technique. Dose parameters for the planning target volume (PTV) and the organs-at-risk (OARs) were compared between the sIMRT and the helical tomotherapy plans. The helical tomotherapy plans showed better dose homogeneity in the PTV, better dose conformity around the PTV, and, therefore, better sparing of nearby OARs compared with the sIMRT plans. In-vivo skin dose measurements were performed during conformal avoidance helical tomotherapy treatment of an anal cancer patient to verify adequate delivery of skin dose and sparing of OARs.
机译:这项研究评估了使用螺旋断层疗法进行保形避免治疗肛门腺癌的疗效。我们回顾性地为采用sIMRT技术治疗的两名肛门癌患者(一男一女)制定了逐步调强放射治疗(sIMRT)计划和螺旋断层放疗计划。比较了sIMRT和螺旋CT方案中计划目标体积(PTV)和高危器官(OAR)的剂量参数。与sIMRT计划相比,螺旋断层扫描计划在PTV中显示出更好的剂量均一性,在PTV周围具有更好的剂量一致性,因此,邻近OAR的备用性更好。在对肛门癌患者进行保形避免螺旋断层扫描治疗期间进行了体内皮肤剂量测量,以验证皮肤剂量是否适当输送和是否保留OAR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号